JPH03158173A - Semisolid drug coating device - Google Patents

Abstract

PURPOSE:To perform easy, reliable, and sanitary coating work by a method wherein the surface portion, with which a semisolid drug is brought into contact, of a protection sheet is coated with a semisolid drug adhesion suppressing material, and the protection sheet is fixed to a coating device body in a manner to be capable of being peeled off. CONSTITUTION:A coating device body 2 is formed of a resin sheet having proper flexibility, and a resin sheet 3 with a thickness of 0.1-3mm producing no eluent even when it makes contact with a drug, e.g. polypropylene, polyethylene, polyester, is well suitably used. A film layer having gas barrier properties may be formed on the upper surface of the coating device body 2. An adhesion resin layer may be formed on the under surface of the coating device body 2. Through formation of the film layer having gas barrier properties, a semisolid drug 5 is prevented from dnaturation due to permeation of a moisture content in the semisolid drug 5 with which the interior is filled or permeation of oxygen from the outside.

Description

DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a semi-solid drug container filled with a semi-solid drug such as an ointment or cream. In particular, the present invention relates to a semi-solid drug applicator that can directly apply semi-solid drugs.

[Prior Art] Conventionally, when used as a container for filling a semi-solid object, for example, a semi-solid drug, a small diameter threaded portion is formed in the opening at one end, the opening can be opened and closed by screwing in a cap, and the other end is made flat. Cylindrical metal containers that were pressed closed were commonly used.

However, such conventional semi-solid drug containers are filled with an amount of semi-solid drug that can be used multiple times, and furthermore, it is not possible to apply semi-solid drugs directly to the affected area using the semi-solid drug container. Therefore, the finger was brought into contact with the opening of the semi-solid drug container, the semi-solid drug was applied to the finger, and then applied to the affected area. Therefore, there was a risk of secondary infection and the opening of the semi-solid drug container was also likely to be contaminated.

Therefore, there has been a need for a semi-solid drug container that is suitable for filling the amount of semi-solid drug required for one application and that also allows the application work to be performed easily and hygienically.

As a product that satisfies the above requirements,
There is one disclosed in Japanese Patent No. 39231.

[Problem to be Solved by the Invention 1] The semi-solid drug container disclosed in the above publication has a flexible tab provided around the opening of the container or on the opening piece that closes the opening. It is configured to apply a drug, and this semi-solid drug container also has sufficient effects. However, the opening piece only covers the area near the opening, and when applying semi-solid medicine to the affected area,
The semi-solid drug adheres to the portion that is not covered by the opening piece, and the application to the affected area is performed in this portion as well. In addition, the unsealed parts may have bacteria attached to them, so they were not perfect in terms of hygiene.

SUMMARY OF THE INVENTION Therefore, an object of the present invention is to provide a semi-solid drug container which is suitable for filling the amount of semi-solid drug required for one application and which allows the application work to be performed easily, reliably and hygienically. It is something.

[Means for Solving the Problems] What achieves the above object is an applicator body, a semi-solid drug applying member provided on the applicator body, and a semi-solid drug applicator attached to the surface of the applicator member. The protective sheet comprises a drug and a protective sheet covering the semi-solid drug, the protective sheet having a semi-solid drug adhesion inhibiting substance applied to a surface area in contact with the semi-solid drug, and removably fixed to the applicator body. It is a semi-solid drug applicator.

The protective sheet preferably has an adhesive resin layer and a gas barrier film layer provided under the adhesive resin layer. Moreover, it is preferable that the said protective sheet has a peeling start part for peeling off this protective sheet.

Furthermore, it is preferable that the semi-solid drug application member is formed of a material that has a soft feel and has low absorbency for semi-solid drugs. The applicator body may have a recess, and the semi-solid drug application member may be attached to the recess. The semi-solid drug application member is made of cellulose, polypropylene,
It is preferably formed of polyester, nylon nonwoven fabric, woven fabric, or porous membrane. Further, the semi-solid drug adhesion inhibiting substance is preferably a water-repellent substance, such as silicone.

Further, the device that achieves the above object includes an applicator body having a through hole, a semi-solid drug applicator provided on one side of the applicator body so as to cover the through hole, and a protective sheet that covers the member, further has a semi-solid drug adhesion inhibiting substance applied to a surface area corresponding to the application member, and is removably fixed to the applicator body; and the other opening of the through hole. a breakable thin film provided on the other side of the applicator main body so as to cover the hole, a semi-solid drug attached to the surface of the thin film, and the applicator main body so as to cover the semi-solid drug. This is a semi-solid drug applicator consisting of a semi-solid drug coating film fixed to a semi-solid drug coating film.

Preferably, the semi-solid drug application member has a pore that communicates with the through hole of the applicator body.

Therefore, the semi-solid drug applicator of the present invention will be specifically explained with reference to embodiments shown in the drawings.

The semi-solid drug applicator 1 of the present invention includes an applicator main body 2,
It consists of a semi-solid drug application member 4 provided on the applicator body 2, a semi-solid drug 5 attached to the surface of the applicator member, and a protective sheet 3 that covers the semi-solid drug 5. A semi-solid drug adhesion inhibiting substance 6 is applied to the surface area that the solid drug 5 comes into contact with, and is removably fixed to the applicator body 2.

Therefore, the semi-solid drug applicator of the present invention will be explained using the embodiment shown in FIGS. 1 and 2. FIG.

FIG. 1 is a sectional view of a semi-solid drug applicator according to an embodiment of the present invention, and FIG. 2 is a plan view of the semi-solid drug applicator of FIG. 1.

The semi-solid drug applicator 1 of this embodiment has an applicator main body 2.
and a protective sheet 3 whose peripheral edge is releasably fused to the lower surface of the applicator main body 2.

As shown in FIG. 1, the applicator main body 2 is provided with a drug applicator 4 near the left end. The applicator main body 2 is formed of a resin sheet having appropriate flexibility, for example, a resin sheet with a thickness of 0.1 to 3xg made of polypropylene, polyethylene, polyester, etc., which does not elute even when it comes into contact with the drug. is preferably used.

Further, the applicator main body 2 may be provided with a gas barrier film layer on its upper surface. Furthermore, the applicator main body 2 may be provided with an adhesive resin layer on its lower surface. By providing a gas barrier film layer, it is possible to prevent the semi-solid drug from being denatured due to permeation of moisture in the semi-solid drug filled inside or permeation of oxygen from the outside.

This gas barrier film layer may be a metal foil such as aluminum, silver, or gold, or a metal vapor-deposited film on the surface of which aluminum, silver, or gold is vapor-deposited, or a gas barrier resin film, such as polyvinylidene chloride, polyvinyl chloride, or Films such as vinylidene chloride-polyvinyl chloride and high-density polyethylene can be suitably used. Further, the adhesive resin layer is for adhering the protective sheet 3 and the coating member 4, and may be provided at least at the periphery of the applicator main body 2 and the area where the coating member 4 is to be fixed. . As the adhesive resin layer, polyolefins such as polyethylene and polypropylene, and heat-melting resins such as ethylene-vinyl acetate copolymers are preferably used. Furthermore, a surface protective layer may be provided as the top layer of the applicator body 2. The surface protective layer can be formed by coating a synthetic resin such as polyester, polypropylene, polyethylene, nylon, PET, epoxy resin, or polyamide resin, or by laminating the above synthetic resin films, paper, etc. preferable. This surface protective layer can also be used as a printing layer for writing necessary information such as the name of the object to be filled and the amount of filling.

A semi-solid drug applicator 4 is fixed near the left end of the applicator main body 2. This application member is used to apply a drug to a wound, and is preferably made of a material that is soft to the touch.

The size of the application member is preferably about 1750 to 174 times the area of the lower surface of the application device main body 2, and specifically,
Approximately 2×2 mm to 30×30a+x is preferable.

Furthermore, it is preferable that it can be fixed to the applicator main body 2 described above without using an adhesive.

For example, if the surface of the applicator body 2 that is fixed to the applicator member 4 does not have heat-fusible properties, the applicator 4 itself has heat-fusible properties, and specifically, Non-sprayed fabrics, sprayed fabrics, and porous membranes such as polyester, polypropylene, polyethylene, etc. are suitable. In addition, if at least the part of the applicator body 2 that fixes the applicator member 4 has heat-adhesive properties, the adhesion surface melts and penetrates between the fibers, making it possible to bond. For example, nonwoven fabrics such as cellulose, woven fabrics, and porous membranes are suitable. In addition,
When the applicator main body 2 has thermal adhesive properties, the applicator main body 2 and the application member 4 are co-extruded to fix the application member 4, or the applicator main body 2 and the application member 4 are laminated. In this state, the coating member 4 can also be fixed to the applicator main body 2 by passing a heated needle or the like through both members.

A semi-solid drug is attached to the surface of the application member 4. Semi-solid drugs such as ointments, creams, gels, and viscous lotions are used as semi-solid drugs. Further, the amount of the semi-solid drug to be adhered to the application member 4 is preferably about 1 to 5 g OO.

The protective sheet 3 is removably fixed to the lower surface of the applicator main body. The protective sheet 3 preferably has a gas barrier film layer and an adhesive resin layer provided on this layer. The gas barrier film layer is for preventing denaturation of the semi-solid drug due to permeation of moisture in the semi-solid drug filled inside or permeation of oxygen from the outside. Examples of the gas barrier film layer include gold foils made of aluminum, silver, gold, etc., metal vapor-deposited films on the surface of which aluminum, silver, gold, etc. are vapor-deposited, gas barrier and other resin films, such as polyvinylidene chloride, polychloride, etc. Films such as vinylidene-polyvinyl chloride and high-density polyethylene can be suitably used. The adhesive resin layer is for fusing the periphery of the protective sheet 3 with the periphery of the applicator body 2, and must be provided at least on the periphery of the surface of the protective sheet 3 that comes into contact with the applicator body 2. Bye. As the adhesive resin layer,
polyolefins such as polyethylene and polypropylene,
Hot-melt resins such as ethylene-vinyl acetate copolymers are preferably used. Furthermore, if the fusion surface of the applicator main body 2 described above is formed of a low melting point resin, this adhesive resin layer only needs to have a certain degree of heat melting property, and does not need to be of a low melting point. It may be formed from polyester, polypropylene, polyethylene, nylon, PET, epoxy resin, polyamide resin, or the like. Further, if the gas barrier film layer can be directly fused to the applicator main body 2, this adhesive resin layer may be omitted. A semi-solid drug adhesion inhibiting substance is applied to the inner surface of the protective sheet 3 in the portion that comes into contact with the semi-solid drug.

This adhesion inhibiting substance is used to prevent the drug from adhering to the protective sheet when the protective sheet is peeled off from the applicator body, and includes organoborisaxane, methylphenylpolysiloxane, dimethylpolysiloxane,
Methylpolycyclosiloxane, acrylallylpolysiloxane, silicone polyether copolymers, trimethylsiloxysilicic acid, amino-modified siloxanes, silicone emulsions, silicones such as trifluoropropylmethylpolysiloxane, or when the semisolid drug is a hydrophilic base. Liquid paraffin, polyethylene glycol, etc. can be used when the semi-solid drug is a lipophilic base. As shown in FIGS. 1 and 2, a peeling start part 7 for peeling off the protective sheet 3 is formed at the end of the protective sheet 3.

The semi-solid drug applicator 1 of the present invention is manufactured by forming the applicator body 2 and the protective sheet 3 on which the semi-solid drug is adhered to the surface of the applicator member as described above. It is created by fusing the periphery of the sheet 3 with heat, ultrasonic waves, high frequency waves, etc.

Next, the semi-solid drug applicator of the embodiment shown in FIGS. 3 and 4 will be described.

In the semi-solid drug applicator 1 of this embodiment, the basic configuration of the applicator main body 2 and the protective sheet 3 is as shown in FIGS. 1 and 2.
It is the same as shown in the figure.

The difference is the position where the semi-solid drug application member is attached and the shape of the applicator main body 2 corresponding to that part. As shown in FIG. 8, the applicator main body 2 has a recess 12 in its center, and the applicator 4 is fixed to the inner surface of the recess 12. Furthermore, the application member 4
A semi-solid drug 5 is attached to the surface of the , and a protective sheet is attached to the part that comes into contact with the semi-solid drug! - The surface of No. 3 is coated with a drug adhesion inhibiting substance. Further, the recessed portion of the applicator main body 2 is formed so that it can be projected by pressing the recessed portion 12 from the outside after peeling off the protective sheet 3, and by curving around the projected recessed portion 12, The semi-solid drug 5 can be easily applied to the wound site.

Next, the coating container 1 of the embodiment shown in FIGS. 5 and 6 will be explained.

This coating container 1 has a through hole 14 that communicates the upper surface and the lower surface.
a semi-solid drug application member 4 provided on the lower surface of the applicator main body 2 so as to cover the through hole 14;
Semi-solid drug adhesion inhibiting substance 6 on the surface area corresponding to
is coated with the protective sheet 3 and removably fixed to the applicator body, a breakable thin film 18 provided on the upper surface of the applicator body 2 at a position corresponding to the applicator member 4, and the surface of the thin film 18. It is formed by a semi-solid drug 5 provided on the device and a semi-solid drug coating film 16 fixed to the applicator body so as to cover the semi-solid drug 5.

The applicator main body 2 has a plurality of through holes 14 near the left end, as shown in FIG.
A drug application member 4 is provided to cover the drug application member 4 . The applicator main body 2 is made of a resin material having appropriate flexibility, and is made of, for example, polypropylene, polyethylene, polyester, etc. with a thickness of 0.1 to 3 cm. Preferably, a resin sheet with no carbon fiber is used. It is preferable to provide about 4 to 30 through holes 14 having diameters of about 0.05 to 2 cm. Also,
The applicator main body 2 may be provided with a gas barrier film layer on its upper surface.

Furthermore, the applicator main body 2 may be provided with an adhesive resin layer on its lower surface. Furthermore, a surface protective layer may be provided as the top layer of the applicator body 2. This surface protective layer can also be used as a printing layer for writing necessary information such as the name of the object to be filled and the amount of filling.

The semi-solid drug application member 4 provided near the left end of the applicator body 2 is used to apply the drug to the wound, and may be made of a material that has a soft feel. preferable. Furthermore, it is preferable that it can be fixed to the above-mentioned applicator body without using an adhesive, and for example, a material that has heat-fusibility is preferable.

For example, if the surface of the applicator body 2 that is fixed to the applicator member 4 does not have heat-fusible properties, the applicator 4 itself has heat-fusible properties, and specifically, Nonwoven fabrics, woven fabrics, and porous membranes such as polyester, polypropylene, and polyethylene are suitable. In addition, if at least the part of the applicator body 2 that fixes the applicator member 4 has heat-adhesive properties, the adhesion surface melts and penetrates between the fibers, making it possible to bond. For example, nonwoven fabrics such as cellulose, woven fabrics, and porous membranes are suitable. In addition,
When the applicator main body 2 has thermal adhesive properties, the applicator main body 2 and the application member 4 are co-extruded to fix the application member 4, or the applicator main body 2 and the application member 4 are laminated. In this state, the coating member 4 can also be fixed to the applicator main body 2 by passing a heated needle or the like through both members. In addition, this application member 4 is a member (for example, a nonwoven fabric, a woven fabric, a porous membrane, etc.) through which the semi-solid drug easily permeates,
If the porosity is high, pores may not be provided.

A breakable thin film 18 is provided on the upper surface of the applicator main body 2 to cover the through hole 14, and a semi-solid drug is further adhered onto this thin film 18. Semi-solid drugs such as ointments, creams, gels, and viscous lotions are used as semi-solid drugs. This semi-solid drug 18 is entirely covered with a semi-solid drug coating film 16, and the periphery of this coating film 16 is fixed to the applicator body. In this embodiment, the semi-solid drug is pressed by pressing the semi-solid drug coating film 16 from the outside, and the force causes the breakable thin film 18 to break and pass through the through hole 14 onto the surface of the semi-solid drug application member 4. is configured to move to. With this configuration, it is possible to prevent the application member 4 and the semi-solid drug 6 from coming into contact with each other until use, prevent the drug from being absorbed by the application member, and keep the drug in a stable state. can be maintained.

The breakable thin film 18 needs to be able to break when the semi-solid drug is pressed as described above, and also not to affect the semi-solid drug (for example, dissolution, additives, etc.). (no elution, etc.) is required. Examples of the thin film 18 that meet these conditions include a metal thin film (for example, aluminum foil), an unstretched or low-stretched polyolefin film (for example, unstretched or low-stretched polyethylene or polypropylene film), or a semi-solid drug based on a lipophilic base. In the case of water-soluble polymer membranes such as polyvinyl alcohol, hydroxymethyl cellulose, sodium dimethyl cellulose, pullulan, and wafer, in the case of hydrophilic bases, they are dissolved in organic solvents such as ethyl cellulose, polyvinyl butyral, alkyd resin, and acrylic resin. It is possible to use a film formed from a resin supplied in the form of a resin or an emulsion.

Further, it is preferable that the semi-solid drug-coated film 16 has a gas barrier film layer and an adhesive resin layer provided on this layer.

The gas barrier film layer is for preventing denaturation of the semi-solid drug due to permeation of moisture in the semi-solid drug filled inside or permeation of oxygen from the outside. This gas barrier film layer may be a metal foil such as aluminum, silver, or gold, or a metal vapor-deposited film with aluminum, silver, or gold deposited on the surface, or a gas barrier resin film such as polyvinylidene chloride or polyvinylidene chloride. - Films such as polyvinyl chloride and high-density polyethylene are suitable for use.

Further, the adhesive resin layer is for fusing the periphery of the covering film 16 to the applicator main body 2, and may be provided at least on the periphery of the covering film 16. As the adhesive resin layer, polyolefins such as polyethylene and polypropylene, and heat-melting resins such as ethylene-vinyl acetate copolymers are preferably used. Furthermore, if the fusion surface of the applicator main body 2 described above is formed of a low melting point resin, this adhesive resin layer only needs to have a certain degree of heat melting property (although it does not need to be of a low melting point). , polyester, polypropylene, polyethylene, nylon, epoxy resin, polyamide resin, etc.Also, if the gas barrier film layer can be directly fused to the applicator body 2, this adhesive resin layer may be omitted.

The protective sheet 3 is removably fixed to the lower surface of the applicator main body. The protective sheet 3 may be a polyolefin such as polyethylene or polypropylene, or a heat-melting resin such as an ethylene-vinyl acetate copolymer, and if the fusion surface of the applicator body 2 is formed of a low-melting resin, This adhesive resin layer only needs to have a certain degree of thermal meltability, does not need to have a low melting point, and may be formed of polyester, polypropylene, polyethylene, nylon, PET, epoxy resin, polyamide resin, or the like.

A semi-solid drug adhesion inhibiting substance is applied to the inner surface of the protective sheet 3 at a position corresponding to the semi-solid drug applying member 4 (a portion in contact with the applying member 4). This adhesion inhibiting substance is for preventing the semi-solid drug that has moved to the surface of the application member 4 by pressing the semi-solid drug coating film 16 from adhering to the protective sheet. Siloxanes, methylphenylpolysiloxanes, dimethylpolysiloxanes, methylpolycyclosiloxanes, acrylallylpolysiloxanes, silicone polyether copolymers, silicones such as trimethylsiloxinsilicate, amide/modified siloxanes, seacone emulsions, triclopropylmethylbolysiloxanes, or If the semi-solid drug has a hydrophilic base,
Liquid paraffin, polyethylene glycol, etc. can be used when the semi-solid drug is a lipophilic base. As shown in FIGS. 5 and 6, the edges of the protective sheet 3 are marked with
A peeling start portion 7 for peeling off the protective sheet 3 is formed.

In the drug applicator of the present invention, after creating the applicator main body 2 and the protective sheet 3 to which the breakable thin film 18 and the application member are fixed as described above, the periphery of the applicator main body 2 and the protective sheet 3 are prepared. After the semi-solid drug is adhered to the breakable thin film 18 by heat, ultrasound, high frequency, etc., the semi-solid drug-coated film 16 is
It is created by fusing the periphery of the coating device to the applicator body using heat, ultrasound, high frequency, etc.

[Function] The function of the semi-solid drug application container of the present invention will be explained using the embodiment shown in FIGS. 1 and 2.

First, the necessary disinfection work is performed on the body part to which the semi-solid drug is to be applied. Then, the protective sheet 3 is peeled off from the applicator main body 2 by placing a finger on the peeling start part 7 provided at the right end of the protective sheet 3 of the coating container B1 of the present invention and pulling. This peeling exposes the lower surfaces of the applicator member 4 and the applicator main body 2 to which the semi-solid drug 5 is attached. Since the lower surface of the applicator main body 2 was originally covered with the upper film, it is a clean surface free from adhesion and propagation of bacteria. And this applicator main body 2
Apply the semi-solid drug 5 to the affected area using the applicator 4 without contaminating the surface of the area, especially the applicator 4 and its vicinity with your fingers.

[Example] (Example 1) The main body of the applicator was a polyethylene sheet (thickness: 11 mm, width: 20 gm, length: 70 gm, near the end of which a cellulose nonwoven fabric (IOX 10x, m product name: Benriichize, Asahi Kasei Corporation) was used, and the protective sheet was made of PET (12μ thick scrap) and aluminum (12μ thick).
A three-layer structure (width 20Rx, length 700zz) of 2μ shoulder, gas barrier film layer) and unstretched polypropylene (thickness 50μm, adhesive resin layer), organoborishixane (Toregi J-Con Co., Ltd.) The sample was partially coated (on top of the non-stretched polypropylene layer) with SH200 oil (manufactured by S.H. Co., Ltd.) near the edges and treated with lOO'C for 4 hours.

Then, the semi-solid drug was placed on the cellulose nonwoven fabric at 0°59
After the coating was applied, the main body of the applicator and the periphery of the protective sheet were heat-sealed as shown in Figure 1. The following semi-solid drugs were used.

Setup
0.59 lidocaine 2.09 Japanese Pharmacopoeia white ointment 909 Liquid paraffin Appropriate amount total 100g The semi-solid drug is 90g of white ointment made by adding cetrimide and lidocaine to 5g of liquid paraffin, stirring, and then heating to 80°C to dissolve. was added, the remaining liquid paraffin was added, and the mixture was cooled while stirring.

This product can be used as an ointment for wounds such as cuts, abrasions, and puncture wounds.

(Example 2) The main body of the applicator was a polypropylene/ethylene copolymer sheet (thickness: lzx, width: 25zz).

A specimen having a length of 10,100 i) and having a concave portion in the center as shown in FIG. 3 was used by hot vacuum molding.

As a semi-solid drug application member, a polypropylene nonwoven fabric with polyethylene bonded by extrusion lamination method (
The polyethylene surface was fused to the applicator body using ultrasonic waves. The same protective sheet as in Example 1 was used, and the semi-solid drug having the following formulation was placed on the nonwoven fabric.

Silver Sulfadiazine 1g White Vaseline
8g stearyl alcohol
39 Isopropyl myristate 5g Span 8029 Polyoxyl stearate 40 4g Bua pyrenegutcol 10g Methylparaben
O, If purified water appropriate amount total 1009 semi-II form 1 m, silver sulfadiazine and methyl paraben are dissolved in propylene glycol. white petrolatum,
Stearyl alcohol, isopropyl myristate, Span 80, polyoxyl stearate 40 at 80'C
Warm up and mix. Separately, after heating purified water to 75°C, add white petrolatum, stearyl alcohol, isopropyl myristate, and Span 80. It was prepared by placing the mixture in a container containing polyoxyl stearate 40, adding propylene glycol, silver sulfadiazine, and methyl paraben, stirring vigorously to emulsify, and gradually cooling while stirring.

When this semi-solid drug container was used on a superficial second-degree burn of l QIX 401R caused by an iron, the semi-solid drug could be easily applied and the burn healed without causing infection.

[Effects of the Invention] The semi-solid drug applicator of the present invention includes an applicator body, a semi-solid drug applicator provided on the applicator body, and a semi-solid drug applicator attached to the surface of the applicator. and a protective sheet covering the semi-solid drug, wherein the protective sheet has a semi-solid drug adhesion inhibiting substance applied to a surface area that comes into contact with the semi-solid drug, and is removably adhered to the applicator body. Since the surface of the applicator body is covered with a protective sheet after the protective sheet is peeled off, the surface is clean and free from adhesion and propagation of bacteria.
When applying a semi-solid drug to an affected area, it is safe even if it comes into contact with a wound site, and the semi-solid drug can be applied hygienically. Further, in the semi-solid drug applicator of the present invention, 1
Since the amount of semi-solid drug required for one application is already attached to the surface of the application member, the application process is easier.

Further, the semi-solid drug application container of the present invention includes: an applicator body having a through hole; a semi-solid drug applicator provided on one surface of the applicator body so as to cover the through hole; a protective sheet that covers the application member, further has a semi-solid drug adhesion inhibiting substance applied to a surface portion corresponding to the application member, and is removably fixed to the applicator body; and the through-hole. a breakable thin film provided on the other surface of the applicator body so as to cover the other opening of the applicator body; a semi-solid drug attached to the surface of the thin film; As described above, since the device consists of a semi-solid drug-coated film fixed to the applicator body, the surface of the applicator device body is covered with the protective sheet after the protective sheet is peeled off, so there is no possibility of bacteria adhesion or Since the surface is clean and free from growth, it is safe to contact the wound site when applying the semi-solid drug to the affected area, and the semi-solid drug can be applied hygienically. Further, the semi-solid drug applicator of the present invention is suitable for filling the amount of semi-solid drug required for one application.

Furthermore, since the drug does not come into contact with the drug application member during storage, the drug can be used effectively without being absorbed by the drug application member, and the drug can be maintained in a stable state until use. be able to.

[Brief explanation of the drawing]

FIG. 1 is an enlarged sectional view of a semi-solid drug applicator according to one embodiment of the present invention, FIG. 2 is an enlarged plan view of the semi-solid drug applicator of FIG. 1, and FIG. 3 is another embodiment of the present invention. 4 is a plan view of the semi-solid drug applicator of FIG. 3, and FIG. 5 is an enlarged sectional view of the semi-solid drug applicator of another example. FIG. 6 is a plan view of the semi-solid drug applicator of FIG. 5. l... Semi-solid drug applicator 2... Applicator body 3... Protective sheet 4...
...Semi-solid drug application member 5...Semi-solid drug 6...Semi-solid drug vicinity suppressing member 7...Peeling start part io...Heat fusion part Fig. 1 Fig. 8 Fig. 2 Figure 4

Claims (10)

[Claims] (1) Consisting of an applicator body, a semi-solid drug application member provided on the applicator body, a semi-solid drug attached to the surface of the applicator member, and a protective sheet covering the semi-solid drug; A semi-solid drug applicator, characterized in that the protective sheet has a semi-solid drug adhesion inhibiting substance applied to a surface area that the semi-solid drug comes into contact with, and is removably fixed to the applicator body. (2) The semi-solid drug applicator according to claim 1, wherein the protective sheet has an adhesive resin layer and a gas barrier film layer provided under the adhesive resin layer. (3) The semi-solid drug applicator according to claim 1 or 2, wherein the protective sheet has a peeling initiation part for peeling off the protective sheet. (4) The semi-solid drug applicator according to any one of claims 1 to 3, wherein the semi-solid drug applicator is made of a material that has a soft feel and has low absorbency for semi-solid drugs. (5) The semi-solid drug applicator according to any one of claims 1 to 4, wherein the applicator body has a recess, and the semi-solid drug applicator is attached to the recess. (6) The semi-solid drug application member may be a nonwoven fabric or woven fabric made of cellulose, polypropylene, polyester, or nylon.
or Claims 1 to 5, wherein the membrane is formed of a porous membrane.
The semi-solid drug applicator according to any one of the above. (7) The semi-solid drug application device according to any one of claims 1 to 6, wherein the semi-solid drug adhesion inhibiting substance is a water-repellent substance. (8) The semi-solid drug applicator according to claim 7, wherein the water-repellent substance is silicone. (9) an applicator body having a through hole; a semi-solid drug applicator provided on one side of the applicator body so as to cover the through hole; A semi-solid drug adhesion inhibiting substance is applied to a surface area corresponding to the application member, and a protective sheet is removably fixed to the applicator body, and A breakable thin film provided on the other side of the applicator body, a semi-solid drug attached to the surface of the thin film, and a semi-solid drug fixed to the applicator body so as to cover the semi-solid drug. A semi-solid drug applicator comprising a coating film. (10) The semi-solid drug applicator according to claim 9, wherein the semi-solid drug applicator has a pore that communicates with the through hole of the applicator body.